Last edition
News about "Immunohistochemistry"
Boston Cell Standards Advances Cancer Testing Tools into FDA Qualification Phase
Boston Cell Standards moves closer to standardising cancer diagnostics as its IHC reference tools enter FDA qualification, aiming to improve accuracy and accelerate therapy development.
Immunohistochemistry | 29/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members